MKB, B., SA, A., AA, K., N, A., MD, A., & HM, A. (2025). Synthesis, in vitro and in silico studies of a novel chrysin-ferrocene Schiff base with potent anticancer activity via G1 arrest, caspase-dependent apoptosis and inhibition of topoisomerase II. Journal of enzyme inhibition and medicinal chemistry, 40(1), 2501377. https://doi.org/10.1080/14756366.2025.2501377
Chicago Style (17th ed.) CitationMKB, Break, Ansari SA, Katamesh AA, Albadari N, Alshammari MD, and Alkahtani HM. "Synthesis, in Vitro and in Silico Studies of a Novel Chrysin-ferrocene Schiff Base with Potent Anticancer Activity via G1 Arrest, Caspase-dependent Apoptosis and Inhibition of Topoisomerase II." Journal of Enzyme Inhibition and Medicinal Chemistry 40, no. 1 (2025): 2501377. https://doi.org/10.1080/14756366.2025.2501377.
MLA (9th ed.) CitationMKB, Break, et al. "Synthesis, in Vitro and in Silico Studies of a Novel Chrysin-ferrocene Schiff Base with Potent Anticancer Activity via G1 Arrest, Caspase-dependent Apoptosis and Inhibition of Topoisomerase II." Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 40, no. 1, 2025, p. 2501377, https://doi.org/10.1080/14756366.2025.2501377.